Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760237 · ClinicalTrials.gov registry record
Cardiovascular Function in Acute Leukemia
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 84
- Enrollment target
NCT03760237 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 84 participants.
The verdict
NCT03760237 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
An observational, prospective study to describe the rates and predictors of cardiovascular events in patients with acute leukemia.
Interventions
- OTHER observation only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2018-12-10 |
| Est. Completion | 2024-05-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03760237
The ClinicalTrials.gov registry entry for NCT03760237 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which observation only is the first listed.
NCT03760237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03760237 about?
NCT03760237 is a clinical study titled "Cardiovascular Function in Acute Leukemia". An observational, prospective study to describe the rates and predictors of cardiovascular events in patients with acute leukemia.
What is the current status of trial NCT03760237?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2018-12-10. Estimated completion is 2024-05-06.
What interventions are being tested in trial NCT03760237?
The interventions under investigation include: observation only (OTHER).
Who is sponsoring clinical trial NCT03760237?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.